Evaluating a new catheter for treating severe strokes

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This clinical investigation aims to assess the safety and effectiveness of the Super-Bore 8/7F aspiration catheters in patients experiencing acute intracranial large vessel occlusion due to ischemic stroke. Participants will be randomly assigned to receive either the new catheter or a conventional thrombectomy device. The study focuses on patients who can undergo mechanical thrombectomy within 24 hours of stroke onset and have specific occlusion characteristics confirmed by angiography. The goal is to determine if the new catheter improves outcomes compared to standard treatment.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Aged 18 years or older;
2. Clinical presentation consistent with acute ischemic stroke (AIS);
3. Able to receive mechanical thrombectomy within 24 hours of onset;
4. Pre-morbid mRS score of 0 or 1;
5. Baseline NIHSS score of 6 or greater;
6. Complete or near-complete occlusion (eTICI 0-1) of the intracranial segment of the internal carotid artery (ICA), the M1 segment of the middle cerebral artery (MCA), or the basilar artery (with or without involvement of the intracranial vertebral artery) confirmed by angiography who can undergo intravascular thrombectomy;
7. Vessel diameter ≥2.2 mm at the occlusion site;
8. ASPECTS or PC-ASPECTS score of 6-10 on NCCT, CTA-source imaging, or DWI-MRI;
9. Written informed consent obtained from the patient or the patient's qualified representative.

Exclusion Criteria:

1. Pregnant or lactating women;
2. Severe allergic reactions to contrast agents;
3. Current participation in other clinical studies;
4. Known hereditary or acquired bleeding disorders, platelet count \<50,000/µL, or coagulation factor deficiencies;
5. Renal failure with serum creatinine ≥3 mg/dL or Glomerular Filtration Rate (GFR) \<30 mL/min;
6. Expected survival \< 6 months or known cancer with metastases;
7. Clinical manifestations suggesting subarachnoid hemorrhage, despite normal CT or MRI findings;
8. Suspected aortic dissection;
9. Known arterial condition in a proximal vessel that requires treatment or prevents access to the site of occlusion or safe recovery of the investigational device (for example, severe stenosis, complete occlusion in the cervical ICA, tandem occlusion);
10. High degree of suspicion of intracranial arterial disease (ICAD), such as evidence of multifocal ICAD on CTA, MRA, or DSA, or any other finding that is highly suggestive of ICAD as the underlying etiology of the occlusion;
11. Evidence of dissection in the extracranial or intracranial cerebral arteries;
12. Intracranial hemorrhage on CT or MRI;
13. Evidence of intracranial mass effect or tumor (except small meningiomas defined as ≤ 3cm and asymptomatic)) on CT or MRI;
14. Suspicious of cerebral vasculitis or infectious endocarditis;
15. Pre-existing neurological or psychiatric disease that would confound the neurological or functional evaluation, e.g., dementia with prescribed anti-cholinesterase inhibitor;
16. Clinical history, past imaging or clinical judgement suggest that the intracranial occlusion is chronic;
17. Excessive vascular access tortuosity or target vessel size that will likely prevent endovascular access with the Super-Bore Aspiration Catheters;
18. Intracranial stent implanted in the same vascular territory that would preclude the safe deployment/removal of the thrombectomy devices;
19. Occlusions in multiple vascular territories (e.g., bilateral anterior circulation, or anterior circulation/vertebrobasilar system) as confirmed on CTA/MRA, or clinical evidence of bilateral strokes or strokes in multiple territories as determined by the treating physician;
20. Known aneurysm at or near the target treatment segment;
21. Known glucose level\< 50 mg/dl (2.78 mmol/L) or \> 400 mg/dl (22.20 mmol/L)；
22. Patients who, in the opinion of the investigator, are unsuitable for mechanical thrombectomy as evidenced by imaging findings.

Where it's running

• The First Affiliated Hospital of University of Science and Technology of China
  Hefei, Anhui, China Recruiting

Study contacts

• Study coordinator: Wei Hu, MD, PhD
• Email: andinghu@ustc.edu.cn
• Phone: +86 055162284313

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Mobilisation After Endovascular Stroke Treatment

  This study checks whether moving around 12 hours after endovascular stroke treatment is as safe as moving around 24 hours for people with an acute ischemic stroke.

  Recruiting at 2 sites Karolinska Institutet · Tampere and 1 other locations · NCT07860333

• Minocycline after successful recanalization in acute anterior circulation stroke

  This trial tests whether adding minocycline after a successful endovascular thrombectomy helps people recover better after an acute anterior circulation stroke.

  Recruiting Phase 2/3 Tongji Hospital · Wuhan, Hubei · NCT07594314

• Minocycline after successful reopening of posterior circulation stroke with endovascular therapy

  This trial tests whether adding minocycline after successful thrombectomy helps people recover better from a posterior circulation stroke.

  Recruiting Phase 2/3 Tongji Hospital · Wuhan, Hubei · NCT07594301

• Evaluating treatment options for stroke patients presenting after 24 hours

  This study is trying to see if a special procedure or the best medical care can help stroke patients who arrive at the hospital more than 24 hours after their symptoms started.

  Recruiting Tianjin Huanhu Hospital · Tianjin, Tianjin Municipality · NCT06200753

• Short-Term outside-in nerve stimulation for acute ischemic stroke

  This trial tests whether a 5-day external trigeminal nerve stimulation given after stroke can help more patients recover better than a sham treatment.

  Recruiting Xidian University · Xi'an · NCT07911605

• Sevoflurane vs. Propofol for anesthesia in stroke patients undergoing clot-removal

  This study tests whether sevoflurane or propofol used for anesthesia during endovascular treatment of an acute ischemic stroke affects the final brain damage and recovery.

  Recruiting Phase 3 Fundació Institut de Recerca de l'Hospital de la Santa Creu i Sant Pau · Barcelona · NCT07902791

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.